Pascal Biosciences Analysis
Pascal Biosciences is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Pascal Biosciences otc analysis is to determine its intrinsic value, which is an estimate of what Pascal Biosciences is worth, separate from its market price. There are two main types of Pascal Biosciences' stock analysis: fundamental analysis and technical analysis.
The Pascal Biosciences otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pascal Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Pascal |
Pascal OTC Stock Analysis Notes
The company recorded a loss per share of 0.01. Pascal Biosciences had not issued any dividends in recent years. Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington. Pascal Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.The quote for Pascal Biosciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Pascal Biosciences contact Brian Bapty at 206 221 3443 or learn more at https://www.pascalbiosciences.com.Pascal Biosciences Investment Alerts
| Pascal Biosciences is not yet fully synchronised with the market data | |
| Pascal Biosciences has some characteristics of a very speculative penny stock | |
| Pascal Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Pascal Biosciences has accumulated 215.65 K in total debt with debt to equity ratio (D/E) of 8.83, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pascal Biosciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pascal Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Pascal Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pascal Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pascal to invest in growth at high rates of return. When we think about Pascal Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.09 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pascal Biosciences has accumulated about 16.91 K in cash with (614.93 K) of positive cash flow from operations. |
Pascal Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pascal Biosciences's market, we take the total number of its shares issued and multiply it by Pascal Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Pascal Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Pascal Biosciences information on this page should be used as a complementary analysis to other Pascal Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Pascal OTC Stock
If you are still planning to invest in Pascal Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pascal Biosciences' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |